vs

Side-by-side financial comparison of MEDIFAST INC (MED) and NPK International Inc. (NPKI). Click either name above to swap in a different company.

NPK International Inc. is the larger business by last-quarter revenue ($75.2M vs $75.1M, roughly 1.0× MEDIFAST INC). On growth, NPK International Inc. posted the faster year-over-year revenue change (30.7% vs -36.9%). NPK International Inc. produced more free cash flow last quarter ($5.8M vs $-6.6M). Over the past eight quarters, NPK International Inc.'s revenue compounded faster (23.9% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

MED vs NPKI — Head-to-Head

Bigger by revenue
NPKI
NPKI
1.0× larger
NPKI
$75.2M
$75.1M
MED
Growing faster (revenue YoY)
NPKI
NPKI
+67.6% gap
NPKI
30.7%
-36.9%
MED
More free cash flow
NPKI
NPKI
$12.4M more FCF
NPKI
$5.8M
$-6.6M
MED
Faster 2-yr revenue CAGR
NPKI
NPKI
Annualised
NPKI
23.9%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MED
MED
NPKI
NPKI
Revenue
$75.1M
$75.2M
Net Profit
Gross Margin
69.4%
37.7%
Operating Margin
-10.4%
16.7%
Net Margin
Revenue YoY
-36.9%
30.7%
Net Profit YoY
EPS (diluted)
$-1.64
$0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
NPKI
NPKI
Q4 25
$75.1M
$75.2M
Q3 25
$89.4M
$68.8M
Q2 25
$105.6M
$68.2M
Q1 25
$115.7M
$64.8M
Q4 24
$119.0M
$57.5M
Q3 24
$140.2M
$44.2M
Q2 24
$168.6M
$66.8M
Q1 24
$174.7M
$49.0M
Net Profit
MED
MED
NPKI
NPKI
Q4 25
Q3 25
$-2.3M
$5.7M
Q2 25
$2.5M
$8.7M
Q1 25
$-772.0K
$10.0M
Q4 24
Q3 24
$1.1M
$-174.3M
Q2 24
$-8.2M
$8.0M
Q1 24
$8.3M
$7.3M
Gross Margin
MED
MED
NPKI
NPKI
Q4 25
69.4%
37.7%
Q3 25
69.5%
31.9%
Q2 25
72.6%
36.9%
Q1 25
72.8%
39.0%
Q4 24
74.1%
39.2%
Q3 24
75.4%
27.5%
Q2 24
73.2%
37.2%
Q1 24
72.8%
36.0%
Operating Margin
MED
MED
NPKI
NPKI
Q4 25
-10.4%
16.7%
Q3 25
-4.6%
13.2%
Q2 25
-1.0%
17.0%
Q1 25
-1.1%
20.9%
Q4 24
0.6%
20.2%
Q3 24
1.5%
2.8%
Q2 24
-4.7%
18.7%
Q1 24
4.5%
14.2%
Net Margin
MED
MED
NPKI
NPKI
Q4 25
Q3 25
-2.5%
8.2%
Q2 25
2.3%
12.7%
Q1 25
-0.7%
15.4%
Q4 24
Q3 24
0.8%
-394.3%
Q2 24
-4.8%
12.0%
Q1 24
4.8%
14.9%
EPS (diluted)
MED
MED
NPKI
NPKI
Q4 25
$-1.64
$0.17
Q3 25
$-0.21
$0.07
Q2 25
$0.22
$0.10
Q1 25
$-0.07
$0.11
Q4 24
$0.08
$0.10
Q3 24
$0.10
$-1.99
Q2 24
$-0.75
$0.09
Q1 24
$0.76
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
NPKI
NPKI
Cash + ST InvestmentsLiquidity on hand
$167.3M
$5.1M
Total DebtLower is stronger
$16.9M
Stockholders' EquityBook value
$198.9M
$351.2M
Total Assets
$248.0M
$441.8M
Debt / EquityLower = less leverage
0.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
NPKI
NPKI
Q4 25
$167.3M
$5.1M
Q3 25
$173.5M
$35.6M
Q2 25
$162.7M
$26.0M
Q1 25
$164.6M
$20.8M
Q4 24
$162.3M
$17.8M
Q3 24
$170.0M
$42.9M
Q2 24
$163.5M
$35.1M
Q1 24
$156.4M
$37.7M
Total Debt
MED
MED
NPKI
NPKI
Q4 25
$16.9M
Q3 25
$9.5M
Q2 25
$9.3M
Q1 25
$8.1M
Q4 24
$7.7M
Q3 24
$14.0M
Q2 24
$58.0M
Q1 24
$77.4M
Stockholders' Equity
MED
MED
NPKI
NPKI
Q4 25
$198.9M
$351.2M
Q3 25
$214.7M
$333.9M
Q2 25
$216.0M
$328.8M
Q1 25
$211.0M
$326.9M
Q4 24
$210.1M
$326.5M
Q3 24
$207.3M
$316.5M
Q2 24
$205.3M
$426.6M
Q1 24
$211.0M
$421.6M
Total Assets
MED
MED
NPKI
NPKI
Q4 25
$248.0M
$441.8M
Q3 25
$268.2M
$404.5M
Q2 25
$269.3M
$393.7M
Q1 25
$280.0M
$390.0M
Q4 24
$284.2M
$393.7M
Q3 24
$291.2M
$389.6M
Q2 24
$293.5M
$624.8M
Q1 24
$302.8M
$640.8M
Debt / Equity
MED
MED
NPKI
NPKI
Q4 25
0.05×
Q3 25
0.03×
Q2 25
0.03×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.04×
Q2 24
0.14×
Q1 24
0.18×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
NPKI
NPKI
Operating Cash FlowLast quarter
$-5.3M
$18.0M
Free Cash FlowOCF − Capex
$-6.6M
$5.8M
FCF MarginFCF / Revenue
-8.8%
7.6%
Capex IntensityCapex / Revenue
1.8%
16.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$26.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
NPKI
NPKI
Q4 25
$-5.3M
$18.0M
Q3 25
$12.1M
$24.7M
Q2 25
$-3.4M
$21.4M
Q1 25
$3.4M
$8.8M
Q4 24
$-4.9M
$-4.1M
Q3 24
$9.1M
$2.8M
Q2 24
$13.1M
$27.6M
Q1 24
$7.3M
$11.9M
Free Cash Flow
MED
MED
NPKI
NPKI
Q4 25
$-6.6M
$5.8M
Q3 25
$10.8M
$12.0M
Q2 25
$-4.8M
$9.7M
Q1 25
$1.9M
$-1.2M
Q4 24
$-7.2M
$-17.7M
Q3 24
$7.7M
$-6.7M
Q2 24
$11.1M
$21.0M
Q1 24
$5.4M
$-1.9M
FCF Margin
MED
MED
NPKI
NPKI
Q4 25
-8.8%
7.6%
Q3 25
12.0%
17.4%
Q2 25
-4.5%
14.3%
Q1 25
1.6%
-1.8%
Q4 24
-6.1%
-30.8%
Q3 24
5.5%
-15.2%
Q2 24
6.6%
31.4%
Q1 24
3.1%
-3.9%
Capex Intensity
MED
MED
NPKI
NPKI
Q4 25
1.8%
16.3%
Q3 25
1.5%
18.5%
Q2 25
1.3%
17.1%
Q1 25
1.3%
15.5%
Q4 24
1.9%
23.6%
Q3 24
1.0%
21.4%
Q2 24
1.1%
9.9%
Q1 24
1.1%
28.3%
Cash Conversion
MED
MED
NPKI
NPKI
Q4 25
Q3 25
4.37×
Q2 25
-1.36×
2.47×
Q1 25
0.88×
Q4 24
Q3 24
8.04×
Q2 24
3.43×
Q1 24
0.88×
1.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

NPKI
NPKI

Rental Revenue$34.8M46%
Products$25.5M34%
Services$14.9M20%

Related Comparisons